Private equity firm Everstone is selling its entire 70 per cent stake in Mumbai-based contract research and drug delivery company Rubicon Research Pvt. Ltd to a global private equity player, it announced on Monday.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
